½ÃÀ庸°í¼­
»óǰÄÚµå
1593935

¸¾¸ð±×·¡ÇÇ ½ÃÀå : Á¦Ç°º°, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Mammography Market by Product (Analog Mammography Systems, Breast Tomosynthesis Systems, Full Field Digital Mammography Systems), End User (Ambulatory Surgical Centers, Diagnostic Centers, Educational and Research Institutes) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 187 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¸¾¸ð±×·¡ÇÇ ½ÃÀåÀº 2023³â¿¡ 30¾ï 8,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2024³â¿¡´Â 33¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 8.79%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 55¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

À¯¹æÃÔ¿µ ½ÃÀåÀº Àú¿¡³ÊÁö ¿¢½º·¹À̸¦ ÀÌ¿ëÇÑ À¯¹æ¾Ï °ËÁø ¹× Áø´Ü°ú °ü·ÃµÈ ½ÃÀåÀ¸·Î, Áúº´ÀÇ Á¶±â ¹ß°ßÀ» µµ¿Í Ä¡·á °á°ú¸¦ °³¼±ÇÔÀ¸·Î½á ÇコÄɾ¼­ Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇϰí ÀÖ½À´Ï´Ù. ¿©¼º °Ç°­¿¡ ÇʼöÀûÀÎ À¯¹æÃÔ¿µ¼úÀÇ Çʿ伺Àº Àü ¼¼°è À¯¹æ¾Ï ¹ßº´·ü Áõ°¡·Î ÀÎÇØ ´õ¿í °­Á¶µÇ°í ÀÖÀ¸¸ç, À̴ ÷´Ü ¿µ»ó ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. À¯¹æÃÔ¿µ¼úÀº ÁÖ·Î º´¿ø, Áø´Ü¼¾ÅÍ, Àü¹® Ŭ¸®´Ð¿¡¼­ »ç¿ëµÇ¸ç, ±× ÃÖÁ¾ ¿ëµµ´Â Å©°í ÀÛÀº ÀÇ·á ½Ã¼³¿¡ À̸£±â±îÁö ´Ù¾çÇϹǷΠÀ̹ÌÁö ǰÁú°ú ȯÀÚ ÆíÀǼºÀ» Çâ»ó½Ã۱â À§ÇÑ ²÷ÀÓ¾ø´Â ±â¼ú ¹ßÀüÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀÇ ¼ºÀåÀº Á¶±â Áø´ÜÀ» Àå·ÁÇÏ´Â Á¤ºÎ ±¸»ó Áõ°¡, À¯¹æ¾Ï À¯º´·ü Áõ°¡, Á¤È®µµ¸¦ ³ôÀ̰í À§¾ç¼º·üÀ» ³·Ãß´Â µðÁöÅÐ ¹× 3D À¯¹æÃÔ¿µ¼ú°ú °°Àº ±â¼ú Çõ½Å¿¡ Å©°Ô ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ ½ÃÀåÀº AI Áö¿ø Áø´Ü Åø¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¿¬±¸·Î ÀÎÇØ ¼±º°°Ë»çÀÇ È¿À²¼º°ú ½Å·Ú¼ºÀ» ³ôÀÏ ¼ö ÀÖ´Â ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª ³ôÀº ºñ¿ë, ÀáÀçÀûÀÎ ¹æ»ç¼± À§Çè, ¿ø°ÝÁö ¹× Àú°³¹ß Áö¿ª¿¡¼­ÀÇ Á¢±Ù¼º Á¦ÇÑ µîÀÇ ¹®Á¦·Î ÀÎÇØ ½ÃÀå È®´ë°¡ Á¦Çѵǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼÷·ÃµÈ ¹æ»ç¼± Àü¹®ÀÇÀÇ ºÎÁ·°ú ÀϺΠ»ç¶÷µéÀÌ °ËÁø ÇÁ·Î±×·¥¿¡ Âü¿©Çϱ⸦ ²¨¸®´Â °Íµµ ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎÀ¸·Î ÀÎÇØ º¸´Ù Æø³ÐÀº Á¢±Ù¼ºÀ» º¸ÀåÇϱâ À§ÇØ »ç¿ëÇϱ⠽±°í ºñ¿ë È¿À²ÀûÀÎ ¿µ»ó ¼Ö·ç¼Ç°ú ÈÞ´ë¿ë ±â¼úÀÇ Çõ½ÅÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. Ÿ±êÆÃµÈ Ä·ÆäÀÎÀ¸·Î ÀÎÁöµµ¸¦ ³ôÀ̰í, °í±Þ À¯¹æ ÃÔ¿µ ±â¼úÀ» º¸´Ù ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï °­·ÂÇÑ º¸»ó ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖ´Â ±âȸ°¡ ÀÖ½À´Ï´Ù. À̹ÌÁö ºÐ¼®À» À§ÇÑ AI¿Í ¸Ó½Å·¯´×¿¡ ´ëÇÑ ÅõÀÚ´Â Áø´Ü Á¤È®µµ¿Í ¾÷¹« È¿À²¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ´Â Å« ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. À̹ÌÁö ǰÁúÀ» À¯ÁöÇϸ鼭 ¹æ»ç¼±·®À» ÁÙÀ̱â À§ÇÑ ¿¬±¸´Â Çõ½ÅÀÇ Àü·«Àû ºÐ¾ßÀÔ´Ï´Ù. À¯¹æÃÔ¿µ¼ú ½ÃÀåÀº ±â¼ú ¹ßÀü, ±ÔÁ¦ Á¤Ã¥, »çȸ¹®È­Àû ¿äÀÎÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀÌ Æ¯Â¡À̸ç, ÀÌÇØ°ü°èÀÚµéÀº »õ·Î¿î ±âȸ¿Í ¿À·£ °úÁ¦¿¡ ¹ÎøÇÏ°í ´Éµ¿ÀûÀ¸·Î ´ëÃ³ÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ[2023] 30¾ï 8,000¸¸ ´Þ·¯
¿¹Ãø³â[2024] 33¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â[2030] 55¾ï 7,000¸¸ ´Þ·¯
CAGR(%) 8.79%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â À¯¹æ Á¶¿µ¼ú ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

À¯¹æÃÔ¿µ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¿ªÀû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • À¯¹æ¾Ï À¯º´·ü »ó½Â
    • À¯¹æ¾Ï Á¶±â¹ß°ß¿¡ ´ëÇÑ ÀǽÄÀÇ Çâ»ó
    • 3Â÷¿ø ÀΰøÁö´É(AI) µµÀÔ À¯¹æÃÔ¿µ¼ú ¼Ò°³
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • À¯¹æ ¿µ»ó Áø´Ü ½Ã½ºÅÛÀÇ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • À¯¹æÃÔ¿µÀ» ÅëÇÑ ÇÏÀ̺긮µå À̹Ì¡ÀÇ ±â¼ú ¹ßÀü
    • À¯¹æ¾Ï °ËÁø Ä·ÆäÀο¡ ´ëÇÑ °¢Á¾ ´ÜüÀÇ ÅõÀÚ Áõ°¡
  • ½ÃÀå °úÁ¦
    • ¹æ»ç¼± ³ëÃâ·Î ÀÎÇÑ ºÎÀÛ¿ëÀÇ À§Ç輺

Portre's Five Forces: À¯¹æ ÃÔ¿µ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·«Àû Åø

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : À¯¹æ ÃÔ¿µ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

PESTLE ºÐ¼® : À¯¹æ ÃÔ¿µ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº À¯¹æÃÔ¿µ¼ú ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® À¯¹æÃÔ¿µ¼ú ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

À¯¹æ ÃÔ¿µ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º À¯¹æÃÔ¿µ¼ú ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â À¯¹æ Á¶¿µ¼ú ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ À¯¹æÃÔ¿µ¼ú ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ

À¯¹æ ÃÔ¿µ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù. :

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù. :

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¸¾¸ð±×·¡ÇÇ ½ÃÀå : Á¦Ç°º°

  • ¾Æ³¯·Î±× ¸¾¸ð±×·¡ÇÇ ½Ã½ºÅÛ
  • À¯¹æ Åä¸ð½ÅÅ׽ýº ½Ã½ºÅÛ
  • ¹è°æ Á¶»ç µðÁöÅÐ ¸¾¸ð±×·¡ÇÇ ½Ã½ºÅÛ

Á¦7Àå ¸¾¸ð±×·¡ÇÇ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • Áø´Ü ¼¾ÅÍ
  • ±³À° Á¶»ç±â°ü
  • º´¿ø

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ¸¾¸ð±×·¡ÇÇ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¸¾¸ð±×·¡ÇÇ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¸¾¸ð±×·¡ÇÇ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Analogic Corporation
  • Canon Medical Systems Corporation
  • Carestream Health
  • Climb Medical Systems, Inc.
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Hologic, Inc.
  • iCAD, Inc.
  • Konica Minolta, Inc.
  • Koninklijke Philips N.V.
  • Medtronic, Inc.
  • Metaltronica S.p.A.
  • Planmeca Oy
  • Siemens Healthineers AG
  • Volpara Health Technologies Ltd.
KSA 24.11.22

The Mammography Market was valued at USD 3.08 billion in 2023, expected to reach USD 3.35 billion in 2024, and is projected to grow at a CAGR of 8.79%, to USD 5.57 billion by 2030.

The mammography market, which involves the screening and diagnosis of breast cancer using low-energy X-rays, plays a vital role in healthcare by aiding early disease detection, thus improving treatment outcomes. Essential for women's health, mammography's necessity is underscored by the increasing incidence of breast cancer worldwide, driving demand for advanced imaging techniques. Primarily applied in hospitals, diagnostic centers, and specialty clinics, its end-use scope extends to both large and small healthcare facilities, necessitating constant technological advancements to improve image quality and patient comfort. Growth in this market is heavily influenced by heightened government initiatives promoting early diagnosis, the rising prevalence of breast cancer, and innovations such as digital and 3D mammography that offer better accuracy and reduced false-positive rates. Moreover, the market benefits from ongoing research into AI-assisted diagnostic tools, providing opportunities to enhance efficiency and reliability of screenings. However, market expansion is tempered by challenges such as the high cost of mammography equipment, potential radiation risks, and limited access in remote and underdeveloped regions. Furthermore, a shortage of skilled radiologists and hesitancy among certain populations to participate in screening programs can hinder growth. The market's limitations compel innovation in user-friendly, cost-effective imaging solutions and portable technologies to ensure wider access. Opportunities lie in increasing awareness through targeted campaigns and establishing robust reimbursement frameworks to make advanced mammography techniques more accessible. Investment in AI and machine learning for image analysis also presents significant potential for improving diagnostic accuracy and operational efficiency. Research into reducing radiation dose, while maintaining image quality, is a strategic area of innovation. The mammography market is characterized by a dynamic interplay of technological advancements, regulatory policies, and sociocultural factors, requiring stakeholders to remain agile and proactive in addressing both emerging opportunities and longstanding challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 3.08 billion
Estimated Year [2024] USD 3.35 billion
Forecast Year [2030] USD 5.57 billion
CAGR (%) 8.79%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Mammography Market

The Mammography Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of breast cancer
    • Growing awareness regarding early detection of breast cancer
    • Introduction of artificial intelligence (AI) in 3D mammography
  • Market Restraints
    • High cost of breast imaging systems
  • Market Opportunities
    • Technological advancements in hybrid imaging with mammography
    • Increasing investment from various organizations in breast cancer screening campaigns
  • Market Challenges
    • Risk of adverse effects from radiation exposure

Porter's Five Forces: A Strategic Tool for Navigating the Mammography Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Mammography Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Mammography Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Mammography Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Mammography Market

A detailed market share analysis in the Mammography Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Mammography Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Mammography Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Mammography Market

A strategic analysis of the Mammography Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Mammography Market, highlighting leading vendors and their innovative profiles. These include Analogic Corporation, Canon Medical Systems Corporation, Carestream Health, Climb Medical Systems, Inc., Fujifilm Holdings Corporation, GE Healthcare, Hologic, Inc., iCAD, Inc., Konica Minolta, Inc., Koninklijke Philips N.V., Medtronic, Inc., Metaltronica S.p.A., Planmeca Oy, Siemens Healthineers AG, and Volpara Health Technologies Ltd..

Market Segmentation & Coverage

This research report categorizes the Mammography Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Analog Mammography Systems, Breast Tomosynthesis Systems, and Full Field Digital Mammography Systems.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, Educational and Research Institutes, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of breast cancer
      • 5.1.1.2. Growing awareness regarding early detection of breast cancer
      • 5.1.1.3. Introduction of artificial intelligence (AI) in 3D mammography
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of breast imaging systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in hybrid imaging with mammography
      • 5.1.3.2. Increasing investment from various organizations in breast cancer screening campaigns
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of adverse effects from radiation exposure
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Mammography Market, by Product

  • 6.1. Introduction
  • 6.2. Analog Mammography Systems
  • 6.3. Breast Tomosynthesis Systems
  • 6.4. Full Field Digital Mammography Systems

7. Mammography Market, by End User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Diagnostic Centers
  • 7.4. Educational and Research Institutes
  • 7.5. Hospitals

8. Americas Mammography Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Mammography Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Mammography Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Analogic Corporation
  • 2. Canon Medical Systems Corporation
  • 3. Carestream Health
  • 4. Climb Medical Systems, Inc.
  • 5. Fujifilm Holdings Corporation
  • 6. GE Healthcare
  • 7. Hologic, Inc.
  • 8. iCAD, Inc.
  • 9. Konica Minolta, Inc.
  • 10. Koninklijke Philips N.V.
  • 11. Medtronic, Inc.
  • 12. Metaltronica S.p.A.
  • 13. Planmeca Oy
  • 14. Siemens Healthineers AG
  • 15. Volpara Health Technologies Ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦